AMG 403

DRUG2 trials

Sponsors

Amgen

Conditions

Chronic PainOsteoarthritis

Phase 1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee Pain

CompletedNCT02318407

AmgenOsteoarthritis

Start: 2006-12-31End: 2008-03-31Updated: 2014-12-17

A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject

CompletedNCT02348879

AmgenChronic Pain

Start: 2005-01-31End: 2006-03-31Updated: 2015-01-30

Related Papers

Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects

Arthritis Research & Therapy2015-10-0826 citations